Biomarkers In Medicine

Biomarkers In Medicine

医学生物标志物

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Biomarkers In Medicine》是由Future Medicine Ltd.出版社于2007年创办的英文国际期刊(ISSN: 1752-0363,E-ISSN: 1752-0371),该期刊长期致力于医学:研究与实验领域的创新研究,主要研究方向为医学-医学:研究与实验。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.1210...%),以发表医学:研究与实验领域等方向的原创性研究为核心(研究类文章占比89.16%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在83篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Biomarkers In Medicine审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约83篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 83 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 127 / 189

33.1%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 131 / 189

30.95%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:3.8 SJR:0.481 SNIP:0.491
学科类别 分区 排名 百分位
大类:Medicine 小类:Biochemistry (medical) Q2 34 / 72

53%

大类:Medicine 小类:Drug Discovery Q3 95 / 157

39%

大类:Medicine 小类:Clinical Biochemistry Q3 75 / 117

36%

期刊发文

  • Association of TLR4 and TLR9 gene polymorphisms with the risk and progression of cervical lesions in HPV-infected women

    Author: Zhang, Chunlin; Yang, Zhiping; Luo, Ping; Ye, Mengxia; Gong, Ping; Gong, Quan; Mei, Bing

    Journal: BIOMARKERS IN MEDICINE. 2022; Vol. 17, Issue 3, pp. 133-142. DOI: 10.2217/bmm-2022-0702

  • Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma

    Author: Sun, Xiaoqing; Cao, Jianghua; Sun, Peng; Yang, Hang; Li, Huan; Ma, Wenjuan; Wu, Xianqiu; He, Xiaohua; Li, Jing; Li, Zhiming; Huang, Jiajia

    Journal: BIOMARKERS IN MEDICINE. 2022; Vol. 17, Issue 3, pp. 143-158. DOI: 10.2217/bmm-2022-0764

  • Low expression of MEOX2 is associated with poor survival in patients with breast cancer

    Author: Wang, Huxia; Tang, Yanan; Wang, Meixia; Zhao, Jing; Ding, Caixia; Yang, Xiaomin; Han, Pihua; Liu, Peijun

    Journal: BIOMARKERS IN MEDICINE. 2023; Vol. 16, Issue 16, pp. 1161-1170. DOI: 10.2217/bmm-2022-0468

  • Association between CYP19A1 rs6493497 and rs936306 polymorphisms and depression susceptibility in the Chinese population

    Author: Peng, Qiuju; Yan, Yuan; Yan, Huacheng; Xie, Guibo; Shi, Lei; Wen, Yuguan; Chang, Qingxian

    Journal: BIOMARKERS IN MEDICINE. 2023; Vol. 16, Issue 16, pp. 1171-1179. DOI: 10.2217/bmm-2022-0370

  • Novel nomogram for predicting coronary vulnerable plaque risk in patients with coronary artery disease

    Author: Liu, Tao; Ji, Hanhua; Jian, Xinwen; Wang, Weiyi; Fan, Zeyuan

    Journal: BIOMARKERS IN MEDICINE. 2023; Vol. 16, Issue 16, pp. 1139-1149. DOI: 10.2217/bmm-2022-0855

  • Novel biomarker panel for the diagnosis and prognosis assessment of sepsis based on machine learning

    Author: Wu, Juehui; Liang, Jianbo; An, Shu; Zhang, Jingcong; Xue, Yimin; Zeng, Yanlin; Li, Laisheng; Luo, Jinmei

    Journal: BIOMARKERS IN MEDICINE. 2023; Vol. 16, Issue 15, pp. 1129-1138. DOI: 10.2217/bmm-2022-0433

  • 3 ' untranslated region variants in DEFA5 gene associated with susceptibility to IgA nephropathy in the Chinese Han population

    Author: Peng, Hongwei; Fan, Pingyun; Hong, Yifen; He, Jing; Zeng, Xiangxiu; Xu, Fengguo; Zhao, Yunxia; Jin, Tianbo

    Journal: BIOMARKERS IN MEDICINE. 2023; Vol. 16, Issue 16, pp. 1151-1159. DOI: 10.2217/bmm-2022-0518

  • Linkage of calprotectin with inflammation, activity and treatment response of rheumatoid arthritis: a meta-analysis

    Author: Zeng, Jiashun; Liu, Xiaoxia; Liu, Jun; Wu, Pengjia; Yang, Lei

    Journal: BIOMARKERS IN MEDICINE. 2023; Vol. 16, Issue 17, pp. 1239-1249. DOI: 10.2217/bmm-2022-0216